Lin, M. (2022). Optimizations of anti-tumor efficacy during CD19-specific chimeric antigen receptor (CAR) T/NK-cell manufacturing.
Chicago-Zitierstil (17. Ausg.)Lin, Min. Optimizations of Anti-tumor Efficacy During CD19-specific Chimeric Antigen Receptor (CAR) T/NK-cell Manufacturing. Heidelberg, 2022.
MLA-Zitierstil (9. Ausg.)Lin, Min. Optimizations of Anti-tumor Efficacy During CD19-specific Chimeric Antigen Receptor (CAR) T/NK-cell Manufacturing. 2022.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.